SALT LAKE CITY--(BUSINESS WIRE)--Oct. 10, 2007--USANA Health Sciences Inc. (NASDAQ:USNA) announced today that it has filed an amended Form 10-Q with the Securities and Exchange Commission (SEC) and NASDAQ.
The amended report includes financial statements as of June 30, 2007 that comply with the reporting requirements of Regulation S-X and subject to the requirements of Statement of Auditing Standards No. 100. Additionally, the amended report includes the certifications by the Company's Chief Executive and Chief Financial Officers, which were omitted from the original filing. An electronic copy of this amended Form 10-Q can be found at http://www.usanahealthsciences.com.
With the filing of the amended quarterly report, the Company now believes that it is in full compliance with all Form 10-Q filing requirements for continued NASDAQ listing set forth in Marketplace Rule 4310(C)(14).
The Company's Audit Committee appointed PricewaterhouseCoopers, LLP as its new independent registered public accounting firm in early September.
About USANA
USANA develops and manufactures high quality nutritional and personal care products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Netherlands, and the United Kingdom. More information on USANA can be found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
CONTACT: USANA Health Sciences Inc.Riley Timmer, 801-954-7100 (Investor Relations)investor.relations@us.usana.comorEdelmanJoe Poulos, 312-240-2719
SOURCE: USANA Health Sciences Inc.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment